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Abstract
YPK9(YeastPARK9;also known asYOR291W)isa non-essential yeast genepredictedbysequencetoencodea transmembrane
P-type transport ATPase. However, its substrate specificity is unknown. Mutations in the human homolog of YPK9, ATP13A2/
PARK9, have been linked to genetic forms of early onset parkinsonism. We previously described a strong genetic interaction
between Ypk9 and another Parkinson’s disease (PD) protein a-synuclein in multiple model systems, and a role for Ypk9 in
manganese detoxification in yeast. In humans, environmental exposure to toxic levels of manganese causes a syndrome
similar to PD and is thus an environmental risk factor for the disease. How manganese contributes to neurodegeneration is
poorly understood. Here we describe multiple genome-wide screens in yeast aimed at defining the cellular function of Ypk9
and the mechanisms by which it protects cells from manganese toxicity. In physiological conditions, we found that Ypk9
geneticallyinteractswithessential genesinvolvedincellulartraffickingandthecellcycle.DeletionofYpk9sensitizesyeastcells
toexposuretoexcessmanganese.Usingalibraryofnon-essential genedeletions,wescreenedforadditionalgenesinvolvedin
tolerance to excess manganese exposure, discovering several novel pathways involved in manganese homeostasis. We
defined the dependence of the deletion strain phenotypes in the presence of manganese on Ypk9, and found that Ypk9
deletion modifies the manganese tolerance of only a subset of strains. These results confirm a role for Ypk9 in manganese
homeostasis and illuminates cellular pathways and biological processes in which Ypk9 likely functions.
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Introduction
Ypk9 (YOR291W) is a non-essential gene in the budding yeast,
Saccahromyces cerevisiae, predicted by sequence to belong to a family
of cationic P-type transport ATPases of unknown substrate
specificity. Recently, mutations in the human homolog of Ypk9,
ATP13A2/PARK9, have been linked to Parkinson’s disease (PD)
and PD-like Kufor-Rakeb syndrome [1]. PD is associated with a
spectrum of diverse genetic and environmental susceptibilities [2].
a-Synuclein (a-syn) is the best studied of the genetic factors, with
point mutations in its coding sequence or duplications and
triplications of its entire locus causing early onset autosomal
dominant forms of familial PD [3,4,5]. a-Syn plays a key role in
sporadic PD as well, being the major component of Lewy bodies,
the proteinaceous inclusions characteristic of the disease [6].
Expression of a-syn in multiple model systems including yeast,
worm, fly, and mouse is sufficient to cause neurodegeneration, and
simple experimental model systems have proven to be an
invaluable tool to gain insight into basic cellular mechanisms by
which a-syn might contribute to disease [7,8,9,10].
When expressed in yeast at low levels, a-syn localizes to the
plasma membrane, consistent with its presynaptic localization in
neurons. Increasing the level of expression causes a growth defect
and relocalization of a-syn to cytoplasmic inclusions composed of
clusters of mislocalized transport vesicles from various steps of the
endocytic and exocytic pathways [11,12,13].
We previously identified Ypk9 as a potent modifier of a-syn
toxicity in an unbiased yeast genetic screen [14,15]. Importantly,
the ability of Ypk9 to rescue a-syn toxicity is conserved and
upregulation of the mammalian PARK9 gene is sufficient to
rescue a-syn-induced neurodegeneration in multiple animal
models [14]. However, the mechanism by which Ypk9 protects
against a-syn toxicity is unknown. Therefore, defining the normal
cellular function of Ypk9 will provide insight into how it is able to
mitigate a-syn toxicity as well as how its loss of function might
contribute to PD.
Subcellular localization studies have revealed that Ypk9 is
localized to the vacuolar membrane in yeast [14], analogous
to the lysosomal localization of ATP13A2 in mammalian cells
[1]. Proper vacuolar localization and ATPase activities are
both required for Ypk9 to protect against a-syn toxicity, since
incorrectly localized patient-based truncation mutants or an
ATPase-dead mutant (D781N) are unable to rescue a-syn toxicity
[14].
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conditions, ypk9D cells are selectively hypersensitive to an excess of
manganese ions in the culture media [14,16]. Accordingly,
overexpression of Ypk9 protects cells from manganese toxicity,
while PD-linked mutations or the ATPase-dead mutant D781N do
not protect [14]. Recently, similar findings have been reported for
the human ortholog, ATP13A2/PARK9, in mammalian cell lines
[17], confirming the value of the yeast model system as a tool to
study genes and pathways relevant to human disease [18].
Manganese (Mn
2+) is a trace element required as an essential
nutrient by all known organisms. Mn
2+ ions are a key cofactor for
a large variety of enzymes present in virtually every compartment
of the cell, such as oxidases and dehydrogenases, DNA and RNA
polymerases, kinases, decarboxylases, sugar transferases, and
superoxide dismutases [19]. At high concentrations, however,
manganese is toxic. In humans, for instance, exposure to
manganese has been associated with a neurological syndrome
called manganism, whose symptoms resemble those of PD [20,21].
For these reasons, control of manganese trafficking and handling is
critical for the cell and must be carefully regulated by cellular
manganese homeostasis pathways, such as cell surface and
intracellular manganese transporters, manganese chaperones and
detoxification factors that sequester or eliminate Mn
2+ from the
cell [19].
Much of our current understanding of manganese homeostatic
mechanisms comes from genetic studies of the budding yeast [22].
Outside of the physiological range of intracellular manganese,
yeast cells are stressed by Mn
2+ deficiency or toxicity, and respond
by upregulating or downregulating cell surface and intracellular
transport systems to normalize intracellular manganese levels [22].
Regulation of manganese transport in yeast does not involve any
known transcriptional pathway, such as those described for
transporters of copper, zinc, and iron. Instead, it occurs at the
post-translational level through changes in transporter protein
localization and turnover [23].
The Nramp Smf1 and Smf2 transporters are largely responsible
for uptake of essential manganese (Smf2) and for oxidative stress
protection (Smf1). Under Mn
2+ replete conditions, ,90% of Smf1
and Smf2 are targeted to the vacuole for degradation, presumably
to limit uptake of toxic amounts of metals. When cells are starved
for manganese, the polypeptides are not delivered to the vacuole
and localize instead to the cell surface (Smf1) and intracellular
vesicles (Smf2) to increase Mn
2+ uptake. In conditions of toxic
metal excess, vacuolar degradation of the Nramp transporters is
enhanced, virtually eliminating Smf1p from the cell [23].
Under manganese surplus conditions, the metal can enter the
cell by an additional route, specifically through the high-affinity
cell surface phosphate transporter Pho84. Accordingly, mutations
in Pho84 and in another yeast gene involved in phosphate
metabolism, Vtc4, are associated with manganese resistance and
lowering of intracellular manganese [24].
An important route of manganese detoxification in yeast is
through Pmr1, a Golgi-localized P-type Ca
2+ and Mn
2+ ATPase,
which sustains the processing and trafficking of proteins moving
through the secretory pathway. Pmr1 provides manganese, an
essential cofactor for protein glycosylation, to sugar transferases,
and transports toxic surplus manganese into the secretory pathway
for excretion [25].
Another route of manganese detoxification in yeast is the
vacuole, a major site for toxic metal ion storage. Thus far, only one
vacuolar manganese (and iron) transporter has been definitively
identified, Ccc1 [26]. Interestingly, Ccc1 was also identified as a
multi-copy suppressor of a-synuclein toxicity in the yeast genetic
screen [15].
Although a few genes involved in Mn
2+ homeostasis have been
identified in yeast, our knowledge of the Mn
2+ homeostasis
network is still limited. Since Ypk9 is localized to the vacuole, the
site of sequestration of excess Mn
2+ in yeast cells, and ypk9D cells
are hypersensitive to Mn
2+, Ypk9 is a good candidate manganese
homeostasis gene. In order to define the cellular function of Ypk9
and the mechanism by which it protects cells from Mn
2+ toxicity,
we took advantage of the power of the yeast system and performed
multiple genetic screens to identify genes and cellular pathways
that interact with Ypk9, in standard culture conditions or in
presence of subtoxic concentrations of Mn
2+. These studies
provide a comprehensive list of yeast genes involved in manganese
homeostasis. Interestingly, we found that some of these manganese
homeostasis genes require Ypk9 function whereas others do not,
indicating a role for Ypk9-dependent and -independent pathways
in protecting against manganese toxicity. These findings pave the
way to functional studies in mammalian systems, providing a
framework for deciphering how genetic and environmental factors
might interact to contribute to PD and other related disorders.
Results
Ypk9 interacts with essential yeast genes
The Ykp9 deletion strain is viable and shows no growth defect
under standard culture conditions ([14] and A.D.G. and A.C.
unpublished observations). To provide insight into Ypk9 cellular
function, we took advantage of the yeast system and performed a
genome-wide synthetic lethal screen. The yeast genome contains
,6,000 genes and ,4,850 of these are non-essential. We used the
synthetic genetic array (SGA) technique to introduce by mating a
Ypk9 deletion (ypk9D) into each yeast deletion strain of two different
libraries: a deletion library of non-essential yeast genes [27] and a
library of ,1,335 temperature sensitive (TS) mutants of essential
genes [28,29]. Following sporulation, we selectively germinated
meiotic progeny containing both the Ypk9 and the gene deletions.
We compared growth of each strain on agar plates containing G418
(single deletion) to that on G418 plus nourseothricin (double
deletion). The phenotype we used in all of these screens was colony
size after growth for three days. Both the non-essential gene
deletions and the TS mutant strains (at the permissive temperature,
25uC) showed no significant growth defect at baseline conditions.
Following multiple rounds of screening, we did not identify any
synthetic sick or lethal (SSL) interaction with any gene in the non-
essential deletion collection. Instead, we identified 12 synthetic sick
interactions with essential genes (Table 1). The 12 double KOs hits
showed more than 50% reduction in colony size compared to the
average colony size of the plate. We repeated the screen three
independent times and we selected only the hits that reproduced
all three times. Furthermore, many of the hits were identified more
than once (because the same strain was duplicated on different
plates in the library) or different mutant alleles of the same gene
were identified.
Most of the hits have a clear human homolog, and are involved
in the cell cycle (APC5, CDC28, CDC53, SFH1, POL3, CDC11,
CDC12), cellular transport and vesicular trafficking (ALG1,
GAB1, BET2, MYO2), or RNA processing (DIM1). One
interesting deletion is BET2, which encodes the beta subunit of
the type II geranylgeranyl transferase required for vesicular
transport between the endoplasmic reticulum and the Golgi, and
provides a membrane attachment moiety to the Rab-like proteins
Ypt1 and Sec4 [30,31]. Interestingly, overexpression of either
Ypt1 or Ypk9 is sufficient to rescue yeast cells from a-synuclein
toxicity, by relieving the block in the ER-to-Golgi trafficking
caused by a-synuclein overexpression [13], and the two genes
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together, these data suggest potential roles for Ypk9 in cell cycle
and vesicular trafficking.
Other notable hits from this screen are the septins CDC11 and
CDC12. Septins are required for cytokinesis in many species [32].
Mammalian septins are abundantly expressed in the CNS, where
they have been implicated in exocytosis [33,34]. Septins have also
been implicated in diverse neurodegenerative disorders in humans
and, intriguingly, in PD and a-synuclein mediated toxicity. Sept4
has been found co-localized with a-synuclein in cytoplasmic
inclusions known as Lewy bodies (LBs) in sporadic PD and
dementia with Lewy bodies and in glial cytoplasmic inclusions in
multiple system atrophy [35]. Sept4 and Sept5/CDCrel-1 are
substrates for a ubiquitin ligase, parkin, which is another familial
PD gene; loss of parkin function may result in inappropriate
accumulation of these paralogous septins [36,37,38]. An acute
overload of Sept5 can be both inhibitory to exocytosis and
neurotoxic [33,38,39]. While mice that lack Sept3, Sept5 or Sept6
do not show obvious CNS abnormalities [40,41,42], Sept4 KO
mice show a specific attenuation of nigrostriatal DA transmission
[43]. Moreover, genetic loss of Sept4 exacerbates neuronal loss,
gliosis and locomotor deterioration in transgenic mice expressing
human ‘‘aaß’’a-synuclein A53T [43]. It is tempting to speculate
that septins and Ypk9 may participate in the same cellular
pathway, and that loss of both septin and Ypk9 function might
synergize, eventually exacerbating a-synuclein toxicity.
A genome-wide screen identifies yeast genes involved in
manganese tolerance
We previously identified Ypk9 as a gene that has a role in
protecting yeast cells from manganese (Mn
2+) toxicity [14].
Although some genes involved in Mn
2+ tolerance have been
reported [44,45,46,47], to our knowledge, there are no published
genome-wide studies defining a comprehensive yeast Mn
2+
homeostasis network. We therefore performed a screen, spotting
a collection of ,4,850 non-essential yeast gene deletion strains
onto plates containing two different concentrations of Mn
2+
(Fig. 1A). We used a lower concentration (12 mM) to identify
deletion strains that were hypersensitive to Mn
2+ toxicity, and
a higher concentration (25 mM) to identify resistant strains. The
baseline phenotypes on 12 mM and 25 mM Mn
2+ plates were a
reduction in colony size of 34% and 76%, respectively. Deletion of
the non-essential genes indicated as ‘‘sensitive’’ hits caused a
growth defect much bigger (colony size less than 50% of the
average colony size in the plate) than the baseline, while deletion
of the ‘‘resistant’’ hits caused a smaller or no growth defect (colony
size more than 175% of the average colony size in the plate).
We identified 67 deletion strains that were sensitive and 72 that
were resistant to Mn
2+ toxicity in three independent rounds of
screening, many with clear human homologs (Tables S1 and S2 in
Online Supporting Information).
The Mn
2+ sensitive hits were enriched in the main functional
categories of vesicle-mediated transport, vacuolar organization
and chromatin remodeling (see Fig. 1C for a complete list of
enriched gene ontology (GO) terms). The first two categories are
expected since, in S. cerevisiae, the main routes of detoxification for
Mn
2+ (as for other toxic metals) are the secretory pathway (through
the Golgi) and the vacuole [22]. All the different steps in vesicular
transport (endosome, vacuole, Golgi) seem to be important for
Mn
2+ detoxification. In particular, we identified all the compo-
nents of the GARP (Golgi-associated retrograde protein) complex
(VPS51, VPS52, VPS53, VPS54) as Mn
2+ sensitive deletions,
together with the Rab GTPase YPT6 and its GTP exchange factor
RGP1/RIC1. These genes work together in the retrograde
transport from endosome to Golgi, which is required for the
recycling of membrane proteins and for vacuolar protein sorting
[48]. Interestingly, mutations in VPS35, a component of the
retromer complex, involved in retrograde transport, were recently
reported as a cause of late-onset PD [49,50].
The other highly enriched category is chromatin organization,
in particular histone exchange. We identified 8 genes belonging to
the SWR1 complex (SWC3, SWC5, SWR1, VPS72, ARP6,
VPS71, YAF9, HTZ1) responsible for exchanging histone variant
H2AZ (HTZ1) for histone H2A in nucleosomes and involved in
transcriptional regulation through prevention of the spread of
silent heterochromatin [51,52].
The Mn
2+ resistant gene network is enriched in the GO
categories of mitochondrial organization/translation, vacuolar
organization and membrane fusion (Fig. 1D). Among the most
resistant deletion strains, we identified the vacuolar transporter
chaperone (VTC) complex members VTC1, VTC2 and VTC3,
Table 1. Essential yeast genes that show synthetic sick interactions with Ypk9.
ts allele Yeast Gene Human Homolog Function
alg1-1 ALG1 ALG1 Mannosyltransferase
cdc28-td CDC28 CDK2 Catalytic subunit of the main cell cycle cyclin-dependent kinase (CDK)
cdc2-1 POL3 POLD1 Catalytic subunit of DNA polymerase delta
cdc53-1 CDC53 CUL1 Cullin, structural protein of SCF complexes
cdc12-td CDC12 SEPT4 Component of the septin ring of the mother-bud neck that is required for cytokinesis
cdc11-4, cdc11-5 CDC11 no Component of the septin ring of the mother-bud neck that is required for cytokinesis
sfh1-1 SFH1 SMARCB1 Component of the RSC chromatin remodeling complex
gab1-1 GAB1 PIGU GPI transamidase subunit
apc5-CA-PAps APC5 no Subunit of the Anaphase-Promoting Complex/Cyclosome (APC/C), which is a ubiquitin-protein
ligase
myo2-16 MYO2 MYO5C One of two type V myosin motors
dim1-2 DIM1 DIMT1L Essential 18S rRNA dimethylase, involved in pre-ribosomal RNA processing
bet2-1 BET2 RABGGTB Beta subunit of Type II geranylgeranyltransferase required for vesicular transport between the
endoplasmic reticulum and the Golgi
doi:10.1371/journal.pone.0034178.t001
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mulation, microautophagy and non-autophagic vacuolar fusion
[53,54,55,56], and the class II histone deacetylase complex
members HDA1, HDA2 and HDA3.
These findings expand our knowledge of manganese homeostasis
in yeast, confirming the importance of the secretory pathway, the
vacuole and the mitochondria in Mn
2+ homeostasis and detoxifi-
cation, and suggest a new role for chromatin remodeling and
histone exchange/modification pathways.
Ypk9 deletion modifies manganese tolerance of a subset
of genes
Having established a comprehensive set of yeast deletion strains that
are either sensitive or resistant to manganese, we next asked whether
these phenotypes were dependent on Ypk9 function. To assess this, we
performed a genetic epistasis analysis by generating double knockouts
(yeast deletion conferring manganese resistance or sensitivity + ypk9D)
a n dc o m p a r e dM n
2+ tolerance of the double mutant strains to baseline
phenotypes of each single deletion strain. The baseline phenotypes for
the double KOs were normal growth on control plates, and 35% and
83% growth defect on 12 mM and 25 mM Mn containing plates,
respectively. The same thresholds described for the single KOs were
applied to identify sensitive and resistant double KOs.
The results are summarized in Table 2. Among the 72 resistant
deletions, we identified 18 strains that lost resistance to Mn
2+ upon
Ypk9 deletion (aggravating interaction), while 32 did not (the
remaining 22 double deletions did not pass quality control; see
Methods). Interestingly, we also identified 5 strains that acquired
Mn
2+ resistance upon Ypk9 deletion (alleviating interaction).
Among the 67 sensitive deletions, we identified 3 strains that lost
sensitivity to Mn
2+ (alleviating interaction) and 16 that did not (48
did not pass quality control). We identified 10 strains that acquired
sensitivity to Mn
2+ upon Ypk9 deletion (aggravating interaction).
We validated the screen results of selected hits by secondary
spotting assays on plates containing different Mn
2+ concentrations
(Fig. 1B).
The genes whose Mn
2+ resistance or sensitive phenotype is
independent of Ypk9 likely work in Mn
2+ homeostasis via
different, independent pathways than those of Ypk9. Another
possibility is that they may be upstream of Ypk9 in the same
pathway (epistatic to Ypk9). An example of this would be a low
affinity Mn
2+ transporter on the plasma membrane, whose
deletion confers resistance to Mn
2+ because the metal cannot
enter the cell; Ypk9 deletion would not have any additional effect
because Ypk9 is active inside the cell, downstream in the pathway.
An example of this kind of interaction that we identified in the
Figure 1. Yeast genetic screens provide insight into the manganese homeostasis network. A, Screen for manganese resistant deletion
strains. A representative plate is shown (each plate contains 384 different yeast deletion strains pinned in duplicate, 768 total colonies). Left, control
plate (0 mM Mn
2+); right, plate containing 25 mM Mn
2+. The red arrow points to a manganese resistant strain, growing better than the other strains
in the presence of a toxic concentration of Mn
2+. B, Manganese resistance in the mam3D strain is independent of Ypk9 function. A representative
spotting assay showing that resistance to Mn
2+ in the mam3D strain is independent of Ypk9. Five-fold serial dilutions of WT, ypk9D, mam3D and
mam3D ypk9D were spotted on SD plates containing different Mn
2+ concentrations. C, Functional categories of genes enriched as manganese
sensitive hits in the Mn
2+ tolerance screen compared to the yeast genome. D, Functional categories of genes enriched as manganese resistant hits in
the Mn
2+ tolerance screen compared to the yeast genome.
doi:10.1371/journal.pone.0034178.g001
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function as a low affinity manganese transporter similarly to
PHO84, another plasma membrane phosphate transporter that
has been shown to play a role in Mn homeostasis [24].
The deletion strains that change their Mn
2+ tolerance
phenotype upon Ypk9 deletion require Ypk9 function to work in
Mn
2+ homeostasis, and these genes are likely to function in the
same pathway as Ypk9. Among these, the deletions that become
more sensitive or less resistant to Mn
2+ upon Ypk9 deletion show
an aggravating interaction. These hits are enriched in the GO
categories of vacuolar and vesicle organization and membrane
fusion, supporting a role for Ypk9 in these cellular processes.
VAM3, for example, is a vacuolar t-SNARE that mediates docking
and fusion of late transport vesicles with the vacuole [57], while
VAM6 is required in the tethering steps of vacuolar membrane
fusion, and they are both required in the delivery of vacuolar
hydrolases [58]. SWF1 is a palmitoyltransferase that acts on
SNAREs and may have a role in vacuolar fusion. GLO3 is an ARF
GAP involved in ER-Golgi transport [59] that, interestingly,
genetically interacts with BET1, which, like BET2 identified by
our TS screen, is important for Ypt1function in vesicular trafficking
[30]. The strains that became less sensitive or more resistant upon
Ypk9 deletion show an alleviating interaction. These hits are
enriched in the GO categories of chromatin organization/histone
modification and nuclear transport. In the first category we
identified SIF2, a subunit of the Set3C histone deacetylase complex,
HMO1,a chromatinassociated high mobilitygroup family member
involved in genome maintenance, and LEO1, which associates with
Table 2. Deletion strains whose Mn
2+ tolerance is dependent or independent on Ypk9.
Mn
2+ Resistant genes Mn
2+ Sensitive genes
Ypk9-independent Ypk9-dependent Ypk9-independent Ypk9-dependent
Systematic Name Common Name Systematic Name Common Name Systematic Name Common Name Systematic Name Common Name
YLR056W ERG3 YDR298C ATP5 YPL259C APM1 YPR051W MAK3
YLL029W FRA1 YFL007W BLM10 YBR164C ARL1 YER122C GLO3
YHR108W GGA2 YHR193C EGD2 YMR198W CIK1 YJR043C POL32
YNL021W HDA1 YDR414C ERD1 YKL190W CNB1 YHR012W VPS29
YOL060C MAM3 YLL049W LDB18 YNL027W CRZ1 YPL196W OXR1
YPL050C MNN9 YDL167C NRP1 YKR019C IRS4 YDL077C VAM6
YHR004C NEM1 YDR289C RTT103 YKL064W MNR2 YOR106W VAM3
YLR093C NYV1 YPL106C SSE1 YMR123W PKR1 YKL113C RAD27
YCR037C PHO87 YPR040W TIP41 YPL179W PPQ1 YDR126W SWF1
YDR435C PPM1 YHR180W YHR180W YJR033C RAV1 YJL053W PEP8
YKR028W SAP190 YIL054W YIL054W YBR231C SWC5 YIL040W APQ12
YER072W VTC1 YLL044W YLL044W YJL004C SYS1 YJR074W MOG1
YJL012C VTC4 YOR199W YOR199W YKL081W TEF4 YMR031W-A YMR031W-A
YHR135C YCK1 YIL145C PAN6 YOL018C TLG2
YDR089W YDR089W YDL095W PMT1 YKR001C VPS1
YDR295C HDA2 YLL030C RRT7 YJL029C VPS53
YPR179C HDA3 YIL047C SYG1
YPL019C VTC3 YEL057C YEL057C
YLR087C CSF1 YNL148C ALF1
YBR014C GRX7 YDR174W HMO1
YDR297W SUR2 YOR123C LEO1
YLR372W SUR4 YHL023C NPR3
YDL122W UBP1 YBR103W SIF2
YML097C VPS9
YML020W YML020W
YLR138W NHA1
YIL153W RRD1
YMR226C YMR226C
YMR015C ERG5
YDL230W PTP1
YGR284C ERV29
YGR285C ZUO1
In normal-face, Ypk9 independent strains; in italics, strains that lose resistance or gain sensitivity (aggravating interactions); in bold-face, strains that either gain
resistance or lose sensitivity (alleviating interactions).
doi:10.1371/journal.pone.0034178.t002
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and MOG1 are instead nuclear proteins involved in RNA and
protein transport, respectively.
Discussion
Mutations in the gene ATP13A3/PARK9 have been recently
associated with familial forms of parkinsonism. Interestingly, the
yeast homologue gene, Ypk9, protects yeast cells from the toxicity
caused by two other insults related to Parkinson’s disease, one
genetic (a-synuclein overexpression) and one environmental
(exposure to high concentrations of manganese). However, Ypk9
is not an essential gene and its normal function is still unclear. To
define the cellular function of Ypk9 and the mechanisms by which
it protects cells from manganese toxicity, we performed multiple
genome-wide screens in yeast.
First, we performed two synthetic lethal screens with a ypk9D
strain, one with a collection of all the ,4,850 non-essential yeast
genes and another with a library of ,1,335 temperature sensitive
mutants of essential genes. We discovered 12 essential genes
interacting with Ypk9, involved in different cellular pathways: the
cell cycle (APC5, CDC28, CDC53, SFH1, POL3, CDC11,
CDC12), cellular transport and vesicular trafficking (ALG1,
GAB1, BET2, MYO2), or RNA processing (DIM1). Interestingly,
among the hits we identified two members (CDC11 and CDC12)
of the septin family. Septins have been implicated in diverse
neurodegenerative disorders in humans and, intriguingly, in PD
and a-synuclein mediated toxicity [35,43].
Second, we investigated the role of Ypk9 in manganese
homeostasis. To do this, we first identified yeast genes involved
in Mn tolerance, spotting a collection of ,4,850 non-essential
yeast gene deletion strains onto plates containing two different
concentrations of Mn
2+, obtaining a comprehensive set of Mn
sensitive and resistant deletions. Among the sensitive hits, we
found genes involved in vesicle-mediated transport, vacuolar
organization and chromatin remodeling, in particular all the
components of the GARP complex and the Rab GTPase YPT6
and its GTP exchange factor RGP1/RIC1, and 8 genes belonging
to the SWR1 complex responsible for exchanging histone variant
H2AZ (HTZ1) for histone H2A in nucleosomes. The resistant hits
were enriched in the GO categories of mitochondrial organiza-
tion/translation, vacuolar organization and membrane fusion,
with the vacuolar transporter chaperone (VTC) complex members
VTC1, VTC2 and VTC3 among the most resistant deletion
strains. To our knowledge, this is the first complete genome-wide
investigation of Mn homeostasis genes in yeast. These results will
provide important clues for a better understanding of Mn biology
in yeast.
With this comprehensive set of Mn homeostasis genes in hand,
we then asked which of these might function with Ypk9 and which
of these function in independent pathways. We generated ypk9D
geneXD double deletions and assessed the effect on Mn tolerance.
This allowed us to classify yeast Mn homeostasis genes as Ypk9-
dependent or independent. Among the Ypk9-dependent hits, the
aggravating interactors (such as VAM3, VAM6, SWF1 and
GLO3) were enriched in the categories of vacuolar and vesicle
organization and membrane fusion, supporting a role for Ypk9 in
these cellular processes. The alleviating interactors (such as SIF2,
HMO1, LEO1, APQ12 and MOG1) were enriched in the
categories of chromatin organization/histone modification and
nuclear transport.
Taken together, these results confirm a role for Ypk9 in
manganese tolerance, identify candidate genes and cellular processes
that interact with Ypk9, and provide a comprehensive list of genes
involved in manganese homeostasis. These data will empower
further investigation into cellular mechanisms of manganese toxicity
and the role of PARK9 in normal biology and neurodegenerative
disease.
Materials and Methods
Yeast strains and culture
The ypk9D strain was obtained by replacing the YPK9 coding
region with the natMX resistance cassette in the Y7092 (genotype:
can1delta::STE2pr-Sp_his5 lyp1delta his3delta1 leu2delta0 ura3delta0
met15delta0) yeast strain background. Colony PCR was used to
verify correct gene disruption. Cells were grown at 30uC on YPD
or complete synthetic medium (CSM). Strains were manipulated
and media prepared using standard techniques.
Synthetic Genetic Array (SGA) screens
These screens were performed as described in [60], with some
modifications, using a Singer RoToR HDA (Singer Instruments,
Somerset, UK). To generate the query strain, the natMX cassette
(confers resistance to clonNAT) was introduced into MATa strain
Y7092 (gift from C. Boone). This query strain was mated to the
yeast haploid deletion collection of non-essential genes (MATa,
each gene deleted with KanMX cassette (confers resistance to
G418)). The heterozygous diploids were transferred to sporulation
media (low levels of carbon and nitrogen) and grown at room
temperature for 5 days. The resulting spores were transferred for 2
days to synthetic medium lacking histidine (SD–His/Arg/Lys +
canavanine, thialysine) to selectively germinate the MATa meiotic
progeny (this step was repeated twice). The MATa meiotic progeny
were transferred, by pinning, to agar plates containing kanamycin
(SD/MSG–His/Arg/Lys + canavanine/thialysine/G418) to select
for the MATa single-mutant progeny, and successively to agar
platescontainingboth nourseouthricinand kanamycin(SD/MSG –
His/Arg/Lys + canavanine/thialysine/G418/clonNAT) to select
for growth of double-mutant haploids. The single and double
selection plates (13 plates each containing 384 deletion mutants,
spotted in duplicates) were photographed at day 3. The entire
screen was repeated 3 times. The TS mutant library screen was
performed in the same way, with a library of 1,335 temperature-
sensitive mutants of essential genes [28,29] spotted onto 5 plates
with each strain spotted in quadruplicate. The plates were
incubated at 25uC instead of 30uC. Colony sizes were measured
using the ht-colony-measurer software [61]. The raw values were
normalized dividing them by the median colony size of the plate.
The data from 3 rounds were averaged and the difference between
double and single mutant colony size was calculated. A threshold of
20.5 was used to call a synthetic sick/lethal interaction.
Manganese tolerance screen
A total of 4799 mutant strains from the yeast haploid deletion
collection of non-essential genes were pinned in duplicate on CSM
plates containing G418 (200 mg/L) and 0, 12 and 25 mM MnCl2.
The plates were grown at 30uC and photographed at day 3. The
screen was repeated 3 times. Colony sizes were measured using the
HT Colony Grid Analyzer software [61]. The raw values were
normalized by the median colony size of the plate. Slow growing
strains in 0 mM Mn
2+ (with average colony size less than half of
the plate median) and duplicate colonies that differed in size more
than their average size were discarded from the analysis. Fitness
was calculated dividing average colony size on Mn
2+ containing
plates by average colony size on control plates. We scored
‘‘sensitive’’ a strain with fitness ,0.5 on 12 mM Mn
2+ plates and
‘‘resistant’’ a strain with fitness .1.75 on 25 mM Mn
2+,i n3
Ypk9 and the Manganese Network in Yeast
PLoS ONE | www.plosone.org 6 March 2012 | Volume 7 | Issue 3 | e34178rounds of screen. To assess whether these phenotypes were
dependent on Ypk9, we mated the library strains with the ypk9D
strain (see SGA screen methods) and repeated the Mn
2+ tolerance
screen with the double mutant strains.
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